Search results for "clinical research"

showing 10 items of 474 documents

Validity of automated refraction after segmented refractive multifocal intraocular lens implantation

2017

Aim To evaluate the clinical utility of automated refraction (AR) and keratometry (KR) compared with subjective or manifest refraction (MR) after cataract or refractive lens exchange surgery with implantation of Lentis Mplus X (Oculentis GmbH) refractive multifocal intraocular lens (IOL). Methods Eighty-six eyes implanted with the Lentis Mplus X multifocal IOL were included. MR was performed in all patients followed by three consecutive AR measurements using the Topcon KR-8000 autorefractor. Assessment of repeatability of consecutive AR before and after dilation with phenylephrine 10%, and comparison of the AR and KR with MR using vector analysis were performed at 3mo follow-up. Results Ana…

medicine.medical_specialtygenetic structuresSpherical equivalentMean differencelaw.invention03 medical and health sciences0302 clinical medicinelcsh:OphthalmologyClinical ResearchlawOphthalmologymedicineDioptreKeratometerbusiness.industry1733autorefractionvector analysisRepeatabilityMultifocal intraocular lensRefractioneye diseasesOphthalmologylcsh:RE1-994Autorefractor030221 ophthalmology & optometrymultifocal intraocular lensessense organsbusinessagreement030217 neurology & neurosurgeryInternational Journal of Ophthalmology
researchProduct

Bone marrow evaluation according to the PVSG and WHO criteria in 90 essential thrombocythemia (ET) patients treated with PEG interferon alpha-2b. Pre…

2005

Abstract Ninety ET patients diagnosed according to the PVSG criteria were enrolled in a phase II study (sponsored by the Schering-Plough Company) designed to evaluate the efficacy, safety and tolerability of a two years treatment with PEG Interferon alpha-2 b (PEG Intron). The patients, observed in 16 Italian Centres belonging to the GIMEMA Cooperative Group and judged at high risk, had been previously treated with cytoreductive (97%) and antiplatelet (91%) drugs. At the study start the patients, 60 F and 30 M, mean age 45 years, showed splenomegaly in 22% of cases. The Hematological Response (HR: PLT<500 x109/L) was observed in 64/81 (79%) and 48/55 (87%) of the patients on PEG Intr…

medicine.medical_specialtythrombocythemia (ET) patientsImmunologyEssential Thrombocythemia (ET); PEG Interferon alpha-2b.Phases of clinical researchAlpha (ethology)BiochemistryGastroenterologyPEG Interferon alpha-2bFibrosisInternal medicinePEG ratioBiopsyMedicineEssential Thrombocythemia (ET)medicine.diagnostic_testbusiness.industryEssential thrombocythemiaCell BiologyHematologymedicine.diseaseSurgerymedicine.anatomical_structureTolerabilityBone marrow evaluationBone marrowbusiness
researchProduct

Klotho and vitamin D in multiple sclerosis: an Italian study

2019

Introduction Low vitamin D levels have been recognised as an important risk factor for autoimmune diseases, including multiple sclerosis (MS). MS is a multifactorial disease, the pathogenesis of which contributes both to genetic and environmental factors. Polymorphisms in genes codifying molecules involved in vitamin D homeostasis have been associated with hypovitaminosis D. However, the influence of polymorphisms of Klotho, which codify a protein with a pivotal role in vitamin D metabolism, have never been investigated. The aim of this study was to evaluate the association among genetic variants of Klotho, namely rs1207568 and rs9536314, serum 25(OH)D3 levels, and multiple sclerosis (both …

medicine.medical_specialtyvitamin D Klotho genetic multiple sclerosisbusiness.industryMultiple sclerosisSingle-nucleotide polymorphismvitamin DGeneral Medicinemedicine.diseasemultiple sclerosisKlotho03 medical and health sciences0302 clinical medicineEndocrinologyClinical ResearchInternal medicineGenotypeGenetic predispositionVitamin D and neurologyMedicine030212 general & internal medicineAllelegeneticbusinessKlothoGenotyping
researchProduct

Is COVID‐19 infection more severe in kidney transplant recipients?

2021

International audience; There are no studies which have compared the risk of severe Covid-19 and related mortality between transplant recipients and non-transplant patients. We enrolled two groups of patients hospitalized for Covid-19, i.e., kidney transplant recipients from the French Registry of Solid Organ Transplant (n=306) and a single-center cohort of non-transplant patients (n=795). An analysis was performed among subgroups matched for age and risk factors for severe Covid-19 or mortality. Severe Covid-19 was defined as admission (or transfer) to an intensive care unit, need for mechanical ventilation, or death.Transplant recipients were younger and had more comorbidities compared to…

medicine.medical_treatment[SDV]Life Sciences [q-bio]MESH: Registries*AucunMESH: Comorbidity030230 surgerylaw.inventionchemistry.chemical_compound0302 clinical medicinelawcardiovascular diseaseMESH: Risk Factors[SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseasesclinical research / practiceImmunology and AllergyCumulative incidencePharmacology (medical)kidney transplantation / nephrologyMESH: IncidenceMESH: AgedUnivariate analysisMESH: France / epidemiologyMESH: Middle AgedMESH: Transplant Recipients / statistics & numerical data*Acute kidney injuryIntensive care unit3. Good healthMESH: COVID-19 / epidemiologyCohort[SDV.MHEP.MI] Life Sciences [q-bio]/Human health and pathology/Infectious diseasesglomerular filtration rate (GFR)kidney failure / injurymedicine.medical_specialtyinfection and infectious agents - viralinfectious diseaseBrief CommunicationMESH: Graft Rejection / prevention & control03 medical and health sciencesInternal medicineDiabetes mellitusMESH: Severity of Illness IndexMESH: COVID-19 / diagnosis*medicineHumansMESH: SARS-CoV-2Mechanical ventilationCreatinineTransplantationMESH: Humansbusiness.industrySARS-CoV-2MESH: Graft Rejection / epidemiology*COVID-19MESH: Retrospective Studiesmedicine.diseaseKidney TransplantationTransplant RecipientsMESH: Maleimmunosuppressive regimensMESH: Immunosuppressive Agents / therapeutic useMESH: Pandemics*MESH: Propensity Score*chemistryReinfectionMESH: Immunosuppression / methodsMESH: Intensive Care UnitsbusinessMESH: FemaleMESH: Kidney Transplantation*
researchProduct

Mid- to Long-Term Outcomes of Cervical Disc Arthroplasty versus Anterior Cervical Discectomy and Fusion for Treatment of Symptomatic Cervical Disc Di…

2015

Purpose This study aimed to investigate the mid- to long-term outcomes of cervical disc arthroplasty (CDA) versus anterior cervical discectomy and fusion (ACDF) for the treatment of 1-level or 2-level symptomatic cervical disc disease. Methods Medline, Embase, and the Cochrane Central Register of Controlled Trials databases were searched to identify relevant randomized controlled trials that reported mid- to long-term outcomes (at least 48 months) of CDA versus ACDF. All data were analyzed by Review Manager 5.3 software. The relative risk (RR) and 95% confidence intervals (CIs) were calculated for dichotomous variables. The weighted mean difference (WMD) and 95%CIs were calculated for conti…

medicine.medical_treatmentlcsh:MedicineAnterior cervical discectomy and fusionIntervertebral Disc Degenerationlaw.inventionDatabase and Informatics MethodsMathematical and Statistical Techniques0302 clinical medicineRandomized controlled triallawMedicine and Health SciencesDatabase Searchinglcsh:ScienceRandomized Controlled Trials as Topic030222 orthopedicsMultidisciplinaryResearch AssessmentTreatment Outcomemedicine.anatomical_structureResearch DesignMeta-analysisPhysical SciencesCervical VertebraeIntervertebral Disc DisplacementStatistics (Mathematics)DiskectomyResearch ArticleCervical vertebraemedicine.medical_specialtyDrug Research and DevelopmentSystematic ReviewsClinical Research DesignVisual analogue scaleSurgical and Invasive Medical ProceduresResearch and Analysis MethodsArthroplasty03 medical and health sciencesMusculoskeletal System ProceduresDiscectomyConfidence IntervalsmedicineHumansClinical TrialsStatistical MethodsPharmacologybusiness.industrylcsh:RArthroplastyRandomized Controlled TrialsSurgeryRelative risklcsh:QAdverse EventsClinical MedicinebusinessMathematics030217 neurology & neurosurgeryMeta-AnalysisPLoS ONE
researchProduct

A Unified Theory of Psychophysical Laws in Auditory Intensity Perception.

2020

Psychophysical laws quantitatively relate perceptual magnitude to stimulus intensity. While most people have accepted Stevens's power function as the psychophysical law, few believe in Fechner's original idea using just-noticeable-differences (jnd) as a constant perceptual unit to educe psychophysical laws. Here I present a unified theory in hearing, starting with a general form of Zwislocki's loudness function (1965) to derive a general form of Brentano's law. I will arrive at a general form of the loudness-jnd relationship that unifies previous loudness-jnd theories. Specifically, the "slope," "proportional-jnd," and "equal-loudness, equal-jnd" theories, are three additive terms in the ne…

medicine.medical_treatmentmedia_common.quotation_subjectlcsh:BF1-990BioengineeringLoudnessWeber's lawStevens's lawClinical ResearchCochlear implantPerceptionHypothesis and TheorymedicineStevens’s lawjust-noticeable-differences (jnd)PsychologyauditoryPower functionUnified field theoryGeneral PsychologyBackward maskingmedia_commonAssistive Technologyintensity discriminationRehabilitationNeurosciencesloudnessWeber’s lawZwislockilcsh:PsychologyLawForward maskingjust-noticeable-differencesCognitive SciencesFechner's lawPsychologyFechner’s lawFree parameter
researchProduct

Nonadherence in outpatient thrombosis prophylaxis with low molecular weight heparins after major orthopaedic surgery

2010

Background: According to some current guidelines, extended thromboprophylaxis after hip and knee arthroplasties is recommended. Outpatient prophylaxis with low molecular weight heparins (LMWH) is an important part of this prophylaxis, although the rates of adherence to these regimens is not known. Questions/purposes: We determined (1) the degree of nonadherence (NA) of patients with LMWH outpatient prophylaxis, and (2) whether specific independent factors explain NA. Methods: NA was determined by syringe count and by indirect and direct questions to patients. We defined six different NA indicators. To identify factors explaining LMWH NA, we used three different logistic regression models. R…

musculoskeletal diseasesMaleQuestionnairesmedicine.medical_specialtyHealth Knowledge Attitudes PracticeTime Factorsmedicine.drug_classmedicine.medical_treatmentArthroplasty Replacement HipLow molecular weight heparinRisk AssessmentInjectionsMedication AdherenceAmbulatory careFibrinolytic AgentsClinical ResearchRisk FactorsInternal medicineSurveys and QuestionnairesGermanyAmbulatory CareMedicineHumansOrthopedics and Sports Medicine/dk/atira/pure/core/keywords/559092180Arthroplasty Replacement KneeAgedbusiness.industryAnticoagulantHealth sciencesThrombosisGeneral MedicineHeparinHeparin Low-Molecular-Weightmedicine.diseaseThrombosisArthroplastySurgeryTelephoneLogistic ModelsTreatment OutcomeOrthopedic surgerySurgeryFemalebusinessFibrinolytic agentmedicine.drug
researchProduct

MDS-191: Long-Term Efficacy and Safety of Luspatercept in Lower-Risk Myelodysplastic Syndromes (MDS): Phase 2 PACE-MDS Study

2020

Background: Luspatercept, a first-in-class erythroid maturation agent, has been investigated in patients with LR-MDS and ring sideroblasts (RS) (MEDALIST; Fenaux and Platzbecker NEJM 2020) and in an ongoing Phase 3 trial regardless of RS status (COMMANDS, NCT03682536 ). The previously reported Phase 2 trial of luspatercept (Platzbecker Lanc Onc 2017) includes subtypes of LR-MDS with and without RS, regardless of prior ESA exposure, and various EPO levels. Aims: Evaluate the long-term safety and efficacy of luspatercept in LR-MDS. Methods: Patients were IPSS low/int-1, age ≥ 18 years, Hgb NCT01749514 ; NCT02268383 ). Results: As of 13July2019, 115 patients were enrolled, of whom 108 were tre…

myalgiaCancer Researchmedicine.medical_specialtyErythemabusiness.industryMyelodysplastic syndromesPeripheral edemaPhases of clinical researchHematologymedicine.diseaseLower riskClinical trialOncologyhemic and lymphatic diseasesInternal medicinemedicinemedicine.symptomBone painbusinessClinical Lymphoma Myeloma and Leukemia
researchProduct

Association of child maltreatment subtypes and long-term physical health in a German representative sample

2018

ABSTRACT Background: Child maltreatment is a major public problem, associated with enormous consequences on the individual and socioeconomic level. Studies show a clear impact of child maltreatment on long-term physical health. However, there is a lack of analyses comprising a wide variety of subtypes of maltreatment and addressing cumulative effects of different maltreatment subtypes experienced during childhood on physical health. Objective: The objective of this analysis was to assess the association of different subtypes and the intensity of child maltreatment with long-term physical health outcomes. Methods: In a cross-sectional observational approach, a representative sample of the Ge…

obesityPsychological interventionObesidadChild abuse and neglectInfarto al Miocardio癌症心肌梗塞0302 clinical medicinelcsh:PsychiatryEnfermedad pulmonar obstructiva crónica030212 general & internal medicineStrokeClinical Research Articlediabetes05 social sciencesCáncerstrokemyocardial infarction• Studies addressing cumulative effects of different child maltreatment subtypes on physical health are sparse especially those comprising emotional and physical neglect.• Odds for obesity diabetes cancer hypertension chronic obstructive pulmonary disease history of myocardial infarction and stroke increased when any kind of child maltreatment was reported.• Growing intensity of each maltreatment subtype was associated with higher rates of all assessed conditions.• Odds for all conditions increased with increasing number of maltreatment subtypes that were experienced.Hipertensión Arterial050104 developmental & child psychologyClinical psychology虐待和忽视儿童medicine.medical_specialtyhypertension高血压lcsh:RC435-571中风physical health outcomesOddschronic obstructive pulmonary disease童年虐待肥胖糖尿病03 medical and health sciencesmedicinecancer0501 psychology and cognitive sciencesAbuso infantil y negligenciaSocioeconomic statusConsecuencias de Salud Físicabusiness.industryPublic healthCTQ treeApoplejíamedicine.diseaseObesity身体健康结果Maltrato infantil慢性阻塞性肺疾病Observational studybusinesschild maltreatmentEuropean Journal of Psychotraumatology
researchProduct

Feasible Low-Phosphorus Dietary Patterns in Maintenance Hemodialysis Patients: Need for Original Research

2020

Introduction The standard low-phosphorus diet restricts pulses, nuts, and whole grains and other high phosphorus foods to control hyperphosphatemia. We conducted a randomized controlled trial to evaluate the effectiveness, safety, and tolerability of the modified diet, which introduced some pulses and nuts, increased the use of whole grains, increased focus on the avoidance of phosphate additives, and introduced the prescription of low-biological-value protein such as bread. Methods We conducted a multicenter, pragmatic, parallel-arm, open-label, randomized controlled trial of modified versus standard diet in 74 adults on hemodialysis with hyperphosphatemia over 1 month. Biochemistry was as…

phosphatesmedicine.medical_specialtybusiness.industrypotassiumPhosphorusMEDLINEchemistry.chemical_elementMaintenance hemodialysisHemodiàlisiOriginal researchchemistryClinical ResearchNephrologyrenal dialysisFòsfor a l'organismemedicineDietadiethyperphosphatemiaIntensive care medicinebusinessKidney International Reports
researchProduct